For the quarter ending 2026-03-31, ISRG had -$1,355,300K decrease in cash & cash equivalents over the period. $808,600K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 826,000 | 799,500 | 709,200 | 664,200 |
| Depreciation and loss on disposal of property, plant, and equipment | 178,900 | 168,400 | 156,700 | 152,100 |
| Amortization of intangible assets | - | - | 3,300 | 3,200 |
| Amortization of intangible and other assets | 21,100 | 62,400 | - | - |
| Accretion of discounts, amortization of premiums, and (gains) losses on investments, net | 10,200 | 14,900 | 14,900 | 9,700 |
| Gain on sale of business and assets | 7,900 | 1,000 | - | - |
| Deferred income taxes | -339,300 | 39,500 | -88,000 | 29,500 |
| Share-based compensation expense | 209,500 | 203,300 | 203,500 | 196,200 |
| Amortization of contract acquisition assets | - | - | 9,600 | 9,100 |
| Accounts receivable | -25,100 | 267,500 | -9,900 | 47,700 |
| Inventory | 266,600 | 253,000 | 316,200 | 283,100 |
| Prepaids and other assets | 269,300 | -61,800 | 107,100 | 134,000 |
| Accounts payable | 73,900 | -39,100 | 24,600 | -10,700 |
| Accrued compensation and employee benefits | -284,700 | 192,900 | 34,700 | 111,100 |
| Deferred revenue | 46,100 | 27,600 | -1,200 | 11,800 |
| Other liabilities | 30,700 | 28,900 | 40,900 | 82,400 |
| Net cash provided by operating activities | 911,900 | 892,500 | 841,000 | 715,400 |
| Purchase of investments | 911,300 | 425,000 | 99,100 | 172,000 |
| Proceeds from sales of investments | - | 10,800 | 0 | 249,100 |
| Proceeds from maturities of investments | 582,300 | 380,000 | 605,500 | 340,100 |
| Proceeds from sale of assets | 46,000 | - | - | - |
| Purchase of property, plant, and equipment | 103,300 | 162,500 | 105,400 | 155,300 |
| Acquisition of business, net of cash, and intellectual property and other investing activities | 528,200 | 12,700 | 0 | 1,200 |
| Net cash provided by (used in) investing activities | -914,500 | -209,400 | 401,000 | 260,700 |
| Proceeds from issuance of common stock relating to employee stock plans | 121,800 | 76,600 | 90,000 | 49,400 |
| Taxes paid related to net share settlement of equity awards | 352,300 | 13,100 | 19,700 | 16,200 |
| Repurchase of common stock | 1,123,200 | 201,000 | 1,913,300 | 181,000 |
| Cash dividends paid by joint venture to noncontrolling interest | - | 0 | 0 | 0 |
| Payment of deferred purchase consideration | - | 0 | 0 | 0 |
| Net cash used in financing activities | -1,353,700 | -137,500 | -1,843,000 | -147,800 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 1,000 | 12,300 | 4,000 | 1,000 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -1,355,300 | 557,900 | -597,000 | 829,300 |
| Cash, cash equivalents, and restricted cash, beginning of period | 3,407,400 | 2,849,500 | 3,446,500 | 2,617,200 |
| Cash, cash equivalents, and restricted cash, end of period | 2,052,100 | 3,407,400 | 2,849,500 | 3,446,500 |
INTUITIVE SURGICAL INC (ISRG)
INTUITIVE SURGICAL INC (ISRG)